MSB 1.01% 98.0¢ mesoblast limited

Crohn’s Disease, page-106

  1. 7,820 Posts.
    lightbulb Created with Sketch. 1344
    Thanks for that.

    That's where I actually got that N of 6 from.

    I was trying to find the published results, rather than the company announcement regarding them.

    They say N of 12. If you follow the citations they link to the actual study results which involve 6 patients.

    So maybe 6 further patients have been involved, and those results aren't in the official interim analysis which they linked.

    So we are simply relying on the overview of results without actual data to rely on at the moment.

    Best case scenario it's an N of 12, and do you think we can safely draw definitive conclusions from an N of 12?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.0¢
Change
-0.010(1.01%)
Mkt cap ! $1.118B
Open High Low Value Volume
99.5¢ $1.02 97.0¢ $2.821M 2.832M

Buyers (Bids)

No. Vol. Price($)
1 20688 97.5¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 35000 3
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.